Medicine and Dentistry
Adverse Event
7%
B Cell
50%
Cell Function
5%
Flow Cytometry
5%
Gut-Associated Lymphoid Tissue
11%
Hazard Ratio
6%
Induction Chemotherapy
25%
Microbiome
5%
Mycobacteria
25%
Named Patient Program
25%
Neoplasm
6%
Overall Survival
10%
Pancreas Adenocarcinoma
25%
Pancreas Cancer
100%
Progression Free Survival
14%
Propensity Score Matching
5%
Rintatolimod
25%
Stereotactic Body Radiation Therapy
25%
Surgery
28%
Survival Rate
7%
Vermiform Appendix
25%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
8%
Antiviral Activity
25%
Chemotherapy
25%
Malignant Neoplasm
25%
Mycobacteria
25%
Overall Survival
10%
Pancreas Cancer
75%
Progression Free Survival
16%
Rintatolimod
50%
SARS Coronavirus
9%
Survival Rate
8%
Toll Like Receptor 3
5%
Vaccination Policy
25%
Immunology and Microbiology
Appendix
25%
B Cell
25%
Bifidobacterium animalis
5%
Cell Activity
5%
Cell Function
10%
Colon
5%
Commensal
5%
Cytotoxic T-Cell
5%
Gene Expression
7%
Gene Expression Profiling
5%
Gut-Associated Lymphoid Tissue
20%
Immune Landscape
10%
Immune Response
7%
Immunocompetent Cell
25%
Immunotherapy
5%
Klebsiella pneumoniae
5%
Marker Gene
25%
MHC Class II
5%
Microbiome
10%
Plasma Cell
5%
Surface Property
5%
